Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05458895 · ClinicalTrials.gov registry record · NA

Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT05458895 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 88 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05458895, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

This clinical trial examines the influence of nicotine form, concentration, and e-liquid flavor on youth vaping behavior, as well as the heart and lung effects associated with this behavior. Electronic cigarette (e-cig) "vaping", while being promoted as a safer alternative to conventional cigarettes, has disproportionately attracted adolescents and young adults ("youth"). This trial may help researchers understand how nicotine form, concentration, and flavor affects people's vaping behaviors and health.

Interventions

  • OTHER ECIG lab session 1
  • OTHER ECIG lab session 2
  • OTHER ECIG lab session 3
  • OTHER ECIG lab session 4
  • OTHER ECIG lab session 5

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2021-12-02
Est. Completion 2023-08-07
Phase NA

What the Registry Record Tells You About NCT05458895

The ClinicalTrials.gov registry entry for NCT05458895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which ECIG lab session 1 is the first listed.

NCT05458895 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05458895 about?

NCT05458895 is a clinical study titled "Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth". This clinical trial examines the influence of nicotine form, concentration, and e-liquid flavor on youth vaping behavior, as well as the heart and lung effects associated with this behavior. Electronic cigarette (e-cig) "vaping", while being promoted as a safer alternative to conventional cigarettes...

What is the current status of trial NCT05458895?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-12-02. Estimated completion is 2023-08-07.

What interventions are being tested in trial NCT05458895?

The interventions under investigation include: ECIG lab session 1 (OTHER), ECIG lab session 2 (OTHER), ECIG lab session 3 (OTHER), ECIG lab session 4 (OTHER), ECIG lab session 5 (OTHER).

Who is sponsoring clinical trial NCT05458895?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.